- Home
- FOLD vs AZZ Comparison
FOLD vs AZZ Comparison
Compare FOLD & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- AZZ
- Stock Information
- Founded
- FOLD 2002
- AZZ 1956
- Country
- FOLD United States
- AZZ United States
- Employees
- FOLD N/A
- AZZ N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- AZZ Industrial Specialties
- Sector
- FOLD Health Care
- AZZ Industrials
- Exchange
- FOLD Nasdaq
- AZZ Nasdaq
- Market Cap
- FOLD 2.9B
- AZZ 3.3B
- IPO Year
- FOLD 2007
- AZZ N/A
- Fundamental
- Price
- FOLD $7.58
- AZZ $112.86
- Analyst Decision
- FOLD Strong Buy
- AZZ Buy
- Analyst Count
- FOLD 10
- AZZ 6
- Target Price
- FOLD $26.89
- AZZ $109.67
- AVG Volume (30 Days)
- FOLD 3.8M
- AZZ 284.7K
- Earning Date
- FOLD 07-31-2025
- AZZ 10-08-2025
- Dividend Yield
- FOLD N/A
- AZZ 0.60%
- EPS Growth
- FOLD N/A
- AZZ 908.98
- EPS
- FOLD N/A
- AZZ 8.62
- Revenue
- FOLD $571,160,000.00
- AZZ $1,586,498,000.00
- Revenue This Year
- FOLD $20.98
- AZZ $6.99
- Revenue Next Year
- FOLD $20.74
- AZZ $4.09
- P/E Ratio
- FOLD N/A
- AZZ $13.05
- Revenue Growth
- FOLD 25.35
- AZZ 1.70
- 52 Week Low
- FOLD $5.51
- AZZ $70.90
- 52 Week High
- FOLD $12.65
- AZZ $117.35
- Technical
- Relative Strength Index (RSI)
- FOLD 69.88
- AZZ 53.48
- Support Level
- FOLD $7.40
- AZZ $114.66
- Resistance Level
- FOLD $7.80
- AZZ $117.00
- Average True Range (ATR)
- FOLD 0.22
- AZZ 2.61
- MACD
- FOLD 0.01
- AZZ -0.29
- Stochastic Oscillator
- FOLD 87.61
- AZZ 34.45
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.